Transvaginal colour and pulsed Doppler ultrasonography analyses of blood flow velocity have indicated that intra-tumoral peak systolic velocity (PSV) is a good indicator of ovarian malignancy. Therefore, we examined whether there was an association between the expression of angiogenic genes, e.g. thymidine phosphorylase (TP) and TIE2 and the PSV of blood flow in normal and cancerous ovaries. Initially, 40 patients were examined by transvaginal ultrasonography and 23 ovaries were surgically removed; 14 were normal with corpora lutea (CL) and nine showed ovarian cancer. The ovarian tissue was dissected according to areas of high blood velocity and gene expression was examined using the reverse transcriptase-polymerase chain reaction (RT-PCR). No significant differences were found between PSV in the normal ovary with CL and ovarian cancer (P ⍧ 0.95). TP gene expression was significantly higher in ovarian cancer than in normal ovary with CL (P ⍧ 0.02), while TIE2 gene expression was not significantly different (P ⍧ 0.186). There was a significant correlation between TIE2 gene expression and PSV in the normal ovary with CL (r ⍧ 0.633, P ⍧ 0.015), while TP expression was significantly correlated with the PSV in ovarian cancer (r ⍧ 0.757, P ⍧ 0.018). These results indicate that there is a biological difference between physiological and pathological angiogenesis, TIE2 having a physiological role and TP being involved in pathological angiogenesis.
Introduction
to be mitogenic for human umbilical vein endothelial cells, and subsequently shown to be thymidine phosphorylase (TP) Transvaginal colour and pulsed Doppler ultrasonography has (Furukawa et al., 1992; Moghaddam et al., 1995) . It was enabled studies of the dynamic vascular patterns in ovarian reported that TP also has chemotactic and angiogenic activity tumours (Bourne et al., 1989; Hata et al., 1992 Hata et al., , 1995 . Analyses (Haraguchi et al., 1994) . of the difference between blood flow velocity waveforms has
The analysis of mRNA for putative angiogenic factors in suggested that intra-tumoral peak systolic velocity (PSV) is ovarian malignancies revealed the over-expression of TP/PDthe best predictor of ovarian malignancy (Hata et al., 1995;  ECGF compared with tissue from benign tumours and the Tailor et al., 1996) . Moreover, the PSV has been shown to normal ovary (Reynolds et al., 1994) . Subsequently, the be significantly associated with the development of healthy concentration of TP in ovarian tumour tissue was shown to be follicles (Collins et al., 1991; Campbell et al., 1993) and the positively correlated with the PSV measured by pulsed-Doppler endocrine function of the corpus luteum (CL) (Bourne et al., ultrasound (Hata et al., 1997) . However, there was no correla-1996) . It is well known that transvaginal ultrasonography tion between the PSV and amount of TP in CL (Hata et al., with colour flow imaging can be used to study intra-ovarian 1997). Although a relatively high PSV was recorded in CL, angiogenesis, which is responsible for follicular and CL the amount of TP was low (Hata et al., 1997) . In normal formation (Campbell et al., 1993) , and tumour development tissues, TP has various subcellular locations and a heterogen- (Hata et al., 1997) . Although PSV is a measure of recent eous pattern of expression with no strong correlation to the vascular activity, we assume that it is directly related to the expected sites of angiogenesis. TP might become angiogenic amount of vascular development, i.e. angiogenesis.
under particular pathological conditions, e.g. in tumours (Fox A growing tumour where the cells are stimulating new et al., 1995) . Therefore, it is anticipated that another factor is capillary sprouts and then accumulating around them appears responsible for angiogenesis in CL. to be analogous to a developing organ in the embryo. However, Physiological angiogenic processes in the adult are the analogy is imperfect because tumours continue to alter restricted to the female reproductive system where they occur their intrinsic vasculature in a way that normal organs do not cyclically during the ovarian and uterine cycle as well as (Folkman, 1985) . These angiogenic processes are probably during pregnancy (Reynolds et al., 1992) . In contrast to induced by factors from within the tumour cell (Folkman pathological angiogenesis, blood vessels in physiological et al., 1971) . One such factor is platelet derived-endothelial angiogenesis maintain their ability to grow and regress throughout life. Sprouting endothelial cells invade the cell growth factor (PD-ECGF), which was initially reported (median 43 years) and all subjects had regular menstrual cycles. The growing CL and continue to grow throughout the first third of final diagnoses were myoma uteri (n ϭ 9), cervical cancer stage Ib the ovarian cycle. Thereafter, the mature CL is characterized (n ϭ 2), serous cystadenoma (n ϭ 2), and haemorrhagic corpus by a dense network of vessels with gradually decreasing vessel luteum (n ϭ 1). The nine patients with ovarian cancer were aged density (Augustin et al., 1995) . An understanding of the 38-75 years (median 55 years); three of them were premenopausal. difference in the angiogenic process between CL and ovarian The tumours were classified as serous cystadenocarcinoma (stage cancer would not only increase our knowledge of pathological Ia) (n ϭ 1), mucinous cystadenocarcinoma (stage Ia) (n ϭ 1), and physiological angiogenesis in the ovary but also might endometrioid carcinoma (stage Ia) (n ϭ 1), clear cell carcinoma point the way to new forms of therapeutic intervention of (stage Ia) (n ϭ 1), serous cystadenocarcinoma (stage IIIc) (n ϭ 4), ovarian cancer. and serous cystadenocarcinoma (stage IV) (n ϭ 1). All patients in Tie2 (also known as Tek) is a novel endothelium-specific this study were different from those in our previous studies (Hata et al., 1997 (Hata et al., , 1999 receptor tyrosine kinase, which has been demonstrated to be essential for development of the embryonic vasculature (Suri Ovarian follicle development depends on the sequential intensity at the maximum amplitude and minimum gate width in simultaneous colour and pulsed Doppler mode was Ͻ 80 mW/ regulation of vascular outgrowth and vascular regression. At cm 2 according to the manufacturer's specifications. The scanning maturation, the follicle ruptures, expels the ovum, and then procedure has been described previously (Hata et al., 1992) .
undergoes reorganization into a cell-dense secretory structure (Reynolds et al., 1994; Hata et al., 1997). derived PSV, as an indicator of angiogenesis (Campbell et al., 1993; Hata et al., 1997) .
Tissue specimen and RNA preparation
Fresh surgical specimens from all patients were obtained, and the tissues for investigation were prepared carefully under a microscope
Materials and methods
to dissect ovaries into cancerous tissue, and healthy tissue around the CL and areas of high blood flow velocity. The tissue samples were Experimental design stored at -80°C for subsequent analysis. As positive control for TP The plan was to recruit and scan patients within 24 h before laparotomy and TIE2 gene expression, normal liver and placental tissues were for a suspected gynaecological disorder. These women were electively used respectively and the breast carcinoma cell line, MCF-7, which admitted to our gynaecology ward. Asymptomatic women with a was kindly provided by Dr Akira Yamauchi, was used as negative positive result from an ovarian cancer screening programme were control for both types of gene expression. excluded. If the ovaries were removed for diagnostic or therapeutic purposes, then a portion of tissue was taken for the TP and TIE2
RT-PCR gene analysis from areas of apparent growth or high vascularity as TIE2 and TP expression were determined by RT-PCR, according indicated by colour Doppler imaging. The remainder of each tissue to the method previously described (Arao et al., 1994) . Briefly, was sent for routine histological investigation. All patients had signed complementary DNA (cDNA) was prepared by random priming from a consent form approved by the Research Ethics Committee of 500 ng of total RNA using a First-Strand cDNA Synthesis kit Shimane Medical University Hospital.
(Pharmacia-LKB, Uppsala, Sweden). The primers for the human TP gene (GenBank accession number M63193) amplification was Patients TGGCTCAGTCGGGACAGCAG (upstream) and TCCGCTGAT-CATTGGCACCT (downstream) (152 bp of PCR product) (Hata et al., A total of 40 patients were recruited and scanned and 23 had ovaries removed, yielding tissues for histological analysis. The 14 1999); and for the human TIE2 gene (GenBank accession number L06139) AACTCTGTGTGCAACTGGTCC (upstream) and AAGTpatients having normal ovaries with CL were aged 21-50 years The PCR conditions were denaturation at 94°C for 1 min, annealing at 58°C for 1 min, and extension at 72°C for 1 min. A total of 30 cycles of PCR were performed for each specimen, and the products were separated on 9% polyacrylamide gels. Then radioactivity was determined using a BAS 2000 Bioimage Analyzer (Fujix, Tokyo, Japan). TP and TIE2 expression were 
Statistical analysis
The Mann-Whitney U-test was used to evaluate significant differences between endpoints, while regression analysis was used to determine the correlation between end-points. P Ͻ 0.05 was considered to be statistically significant.
Results

RT-PCR and TP and TIE2 gene expression
To determine the number of PCR cycles appropriate for quantification, PCR was performed from 20 to 50 cycles in increments of five cycles. The expression ratios of TP and TIE2 to β 2 -HG were reasonably constant from 25 to 40 cycles respectively (data not shown). Therefore, in subsequent experiments, the values at 30 PCR cycles were defined as the expression of target genes. The representative profile of each 
PSV and TP and TIE2 gene expression
The relative gene expression for TP and TIE2 are the mean respectively; P ϭ 0.02, Mann-Whitney U-test) (Figure 3 ). No significant difference was noted between the value of TIE2 values from at least three independent RT-PCR experiments. There was no significant difference between PSV in normal gene expression in the normal ovary with CL (median 0.20, range 0.10-0.47) and that in ovarian cancer (median 0.15, ovary with CL and that in ovarian cancer (median 28.6, range 12.8-42 .3 cm/s versus median 26.8, range 13.8-49.3 cm/s range 0.04-0.35) (P ϭ 0.186, Mann-Whitney U-test) ( Figure  4 ). There was a significant correlation between the TIE2 gene respectively; P ϭ 0.95, Mann-Whitney U-test) (Figure 2 ). The value of TP gene expression in ovarian cancer was expression and the PSV in normal ovary with CL (r ϭ 0.633, P ϭ 0.015) (Figure 5 ), but the corresponding relationship significantly higher than that in normal ovary with CL (median 1.14, range 0.28-2.80 versus median 0.38, range 0.12-1.70
between TP gene expression and the PSV was not signi- significantly with the PSV in ovarian cancer but not with that in CL. Polymerase chain reaction (PCR), is a highly sensitive and efficient method of amplifying specific DNA segments present at low concentrations, and provides an alternative approach for estimating the relative gene expression in small amounts of tissues (Eisenstein, 1990) . By amplifying cDNA reverse-transcribed from RNA, PCR can be used to measure quantitatively the expression of specific genes in tumour cells (Arao et al., 1994) . While gene expression is not a direct measure of enzyme activity, it have been shown that when gene amplification takes place, it is closely related to increases in enzyme concentrations, gene copy number, and mRNA values (Curt et al., 1983) . Moreover, a significant correlation between TP enzyme activity and TP mRNA expression measured by RT-PCR was reported (Mimori et al., 1997) . Therefore, the present results confirm our previous findings systolic velocity in normal ovary with corpus luteum. (Hata et al., 1997) , that intratumoral PSV reflects production of TP in ovarian cancer, and is indicative of angiogenesis. ficant (r ϭ 0.03, P ϭ 0.91). Moreover, TP gene expression Although the difference was not found to be significant, the significantly correlated with the PSV in ovarian cancer (r ϭ value of TIE2 gene expression in CL was higher compared 0.757, P ϭ 0.018) (Figure 6 ), however TIE2 gene expression with that in ovarian cancer. There was a significant correlation did not (r ϭ 0.06, P ϭ 0.88).
between TIE2 gene expression and PSV in CL, but the corresponding relationship between TP gene expression and
Discussion
PSV was not found to be significant. Of course, the expression of TIE2 and TP may vary depending upon the stage of corpus In this study, no significant difference was found between PSV in CL and that in ovarian cancer. This means that at this point luteum development. Unfortunately, the precise time in the menstrual cycle of the patients was not recorded. Nevertheless, in the menstrual cycle, the Doppler study cannot discriminate between physiological and pathological angiogenesis. This transvaginal colour Doppler spectral analysis of the periovulatory phase revealed that the PSV monitors intra-ovarian appears to contradict the finding of previous studies (Hata et al., 1995; Tailor et al., 1996) . However, the results may angiogenesis (Campbell et al., 1993) . Therefore, the TIE2 gene might be one of the key genes that modulate angiogenesis in CL depend upon the time of measurement. In order to determine ovarian malignancy, PSV should be measured on days 5-7 of formation and regression, e.g. in physiological angiogenesis. Angiopoietin-1 (Ang1) and angiopoietin-2 (Ang2) are novel the menstrual cycle in order to avoid the efffect of ovulation and the presence of the CL. The value of TP gene expression 75 kDa secreted ligands for the vascular endothelial-restricted receptor tyrosine kinase, Tie2 (Maisonpierre et al., 1997). in ovarian cancer was significantly higher than that of TP gene expression in CL. TP gene expression was correlated
Although they bind with comparable affinity, Ang1 induces
